You're reading the free version. Trader adds the live tape and alerts.
Start tracking
IDXG Exercise Disclosure
Burnell Thomas W. · SEC Form 4 · Filed Aug 20, 2026
Exercise
Calculated transaction value
$0
Burnell Thomas W. CEO, President & Chairman
IDXG
Transaction date
Aug 20, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed same day
IDXG daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 1,966,763 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-039528
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$936.57K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Interpace Biosciences, Inc. IDXG | Exercise | Aug 20, 2026 | $0 |
| Interpace Biosciences, Inc. IDXG | Disposition | Aug 20, 2026 | $936.57K |
| Interpace Biosciences, Inc. IDXG | Award | Aug 20, 2026 | $0 |
| Interpace Biosciences, Inc. IDXG Current | Exercise | Aug 20, 2026 | $0 |
| Interpace Biosciences, Inc. IDXG | Award | Aug 20, 2026 | $0 |